Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v4-FR | Version v3-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2023-03-29 | 2023-03-29 |
| Drug Identification Number | 02456621 | 02456621 |
| Brand name | SYNJARDY | SYNJARDY |
| Common or Proper name | SYNJARDY 12.5/1000MG 6X10 | SYNJARDY 12.5/1000MG 6X10 |
| Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
| Ingredients | METFORMIN HYDROCHLORIDE EMPAGLIFLOZIN | METFORMIN HYDROCHLORIDE EMPAGLIFLOZIN |
| Strength(s) | 1000MG 12.5MG | 1000MG 12.5MG |
| Dosage form(s) | TABLET | TABLET |
| Route of administration | ORAL ORAL | ORAL ORAL |
| Packaging size | 6X10 | 6X10 |
| ATC code | A10BD | A10BD |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | 2023-03-30 | 2023-03-30 |
| Actual start date | ||
| Estimated end date | 2023-03-30 | 2023-03-30 |
| Actual end date | 2023-03-29 | 2023-03-29 |
| Shortage status | Avoided shortage | Avoided shortage |
| Tier 3 Status | No | No |
| Company comments | Anticipated Shortage due to Inbound Logistics Delay Averted - No Patient Impact expected due to 2-3 weeks inventory on hand at wholesalers | Anticipated Shortage due to Inbound Logistics Delay Averted - No Patient Impact expected due to 2-3 weeks inventory on hand at wholesalers |
| Health Canada comments |